Home / Inspections / 858660

FDA Inspection 858660 — Janssen Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc — FEI 2242843

The FDA completed an inspection of Janssen Pharmaceuticals, Inc on December 12, 2013 in Titusville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 12, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Titusville, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1271223 (NAI Thu Aug 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229931 (VAI Fri Sep 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131617 (NAI Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1131381 (NAI Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031605 (NAI Fri Oct 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources